Free Trial

Cogent Biosciences (COGT) SEC Filings & 10K Form

Cogent Biosciences logo
$11.53 -0.31 (-2.62%)
Closing price 04:00 PM Eastern
Extended Trading
$11.54 +0.02 (+0.13%)
As of 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cogent Biosciences SEC Filings

DateFilerForm TypeView
07/14/2025
3:30 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Fairmount Funds Management LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
3:31 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Fairmount Funds Management LLC (Filed by)
Form SCHEDULE 13D/A
07/11/2025
7:19 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Flynn James E (Filed by)
Form SCHEDULE 13G
07/10/2025
7:00 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025
3:46 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 424B5
07/08/2025
4:14 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 424B5
07/07/2025
6:15 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
7:15 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
3:17 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Morris Arlene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:19 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Harwin Peter Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:21 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Shegog Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:21 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ros Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:24 PM
CAIN CHRISTOPHER W. (Reporting)
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:25 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
7:15 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:39 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SCHEDULE 13G/A
05/11/2025
11:15 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form EFFECT
05/06/2025
8:00 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
7:19 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:05 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form POS AM
05/06/2025
7:10 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 424B5
04/22/2025
3:40 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form ARS
04/22/2025
3:31 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form DEF 14A
04/22/2025
3:35 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form DEFA14A
04/11/2025
5:28 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SCHEDULE 13G/A
02/25/2025
7:38 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
7:20 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:28 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
01/27/2025
4:03 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Green John L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:55 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Kearns Evan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:56 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Robbins Andrew R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:56 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Sachs Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:58 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Robinson John Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:00 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Pinnow Cole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
6:00 AM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Pinnow Cole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
3:21 PM
Cogent Biosciences (Issuer)
Cogent Biosciences, Inc. (Issuer)
Ferrante Karen Jean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:59 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:47 PM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G/A
11/14/2024
11:24 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
Kynam Capital Management, LP (Filed by)
Form SC 13G/A
11/07/2024
8:24 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/07/2024
8:12 AM
Cogent Biosciences (Subject)
Cogent Biosciences, Inc. (Subject)
FMR LLC (Filed by)
Form SC 13G/A
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
09/03/2024
7:15 AM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:53 PM
Cogent Biosciences (Filer)
Cogent Biosciences, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COGT) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners